Pages

Wednesday, 27 October 2021

GlaxoSmithKline has revealed it's made more money than expected in the three months to the end of September.

It’s largely thanks to its drugs and coronavirus vaccines.

The pharmaceuticals giant based in Brentford says turnover grew by five per cent to 9-point-1 billion.

The company had been expecting to hit a lesser figure of around 8-point-7 billion during that period.